Evidence map›Paper›PMID 35740531›Full record

ReviewCancers2022

Clinical Viability of Boron Neutron Capture Therapy for Personalized Radiation Treatment.

Dominika Skwierawska, José Antonio López-Valverde, Marcin Balcerzyk, Antonio Leal

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Quantification ofMedicinal research reviews · 2026
    Review
  3. Article
  4. CD98 Light Chain LAT1 Tracers in PET-CT Diagnosis of Cancer Patients.Anti-cancer agents in medicinal chemistry · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Dominika SkwierawskaDepartment of Biomedical Engineering, Faculty of Electronics, Telecommunications, and Informatics, Gdańsk University of Technology, 80-233 Gdańsk, Poland.ORCID 0000-0002-6531-4049
José Antonio López-ValverdeDepartamento de Fisiología Médica y Biofísica, Facultad de Medicina, Universidad de Sevilla, 41009 Seville, Spain.ORCID 0000-0001-5358-1441
Marcin BalcerzykDepartamento de Fisiología Médica y Biofísica, Facultad de Medicina, Universidad de Sevilla, 41009 Seville, Spain.ORCID 0000-0001-6030-7416
Antonio LealDepartamento de Fisiología Médica y Biofísica, Facultad de Medicina, Universidad de Sevilla, 41009 Seville, Spain.ORCID 0000-0002-0687-5305
Instituto de Biomedicina de Sevilla · ESCentro Nacional de Aceleradores · ESGdańsk University of Technology · PL

Funding

ERASMUS PLUS-European Commission program for 2014-2020 number 2019-1-PL01-KA103-062953MCIN/AEI/ 10.13039/501100011033 and by "ERDF A way of making Europe", by the "European Union" RTI2018-098656-B-100the European Union and the Junta de Andalucía through the European Regional Development Fund (FEDER) P20_01053the FPU call from the Spanish Ministry of Science, Innovation, and Universities FPU19/02950
6 · The paper itself

Abstract

Boron Neutron Capture Therapy (BNCT) is a promising binary disease-targeted therapy, as neutrons preferentially kill cells labeled with boron (

Indexed as

biological dosimetryBNCTboron imagingpersonalized medicinepersonalized oncologytargeted therapy

Identifiers

PMID35740531
PMCPMC9221296
OpenAlexW4281754885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.